Is Prenatal Diagnosis Necessary for Fetal Isolated Nasal Bone Absence or Hypoplasia?

References

• Du Y, Ren Y, Yan Y, Cao L. Absent fetal nasal bone in the second trimester and risk of abnormal karyotype in a prescreened population of Chinese women. Acta ObstetGynecol Scand. 2018;97(2):180–186. doi:10.1111/aogs.13263
   PubMed Web of Science ®Google Scholar
• Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol. 2013;41(3):247–261. doi:10.1002/uog.12364
   PubMed Web of Science ®Google Scholar
• Manegold-Brauer G, Maymon R, Shor S, et al. Down’s syndrome screening at 11–14 weeks’ gestation using prenasal thickness and nasal bone length. Arch Gynecol Obstet. 2019;299(4):939–945. doi:10.1007/s00404-019-05083-2
   PubMed Web of Science ®Google Scholar
• Moreno-Cid M, Rubio-Lorente A, Rodríguez MJ, et al. Systematic review and meta-analysis of performance of second-trimester nasal bone assessment in detection of fetuses with Down syndrome. Ultrasound Obstet Gynecol. 2014;43(3):247–253. doi:10.1002/uog.13228
   PubMed Web of Science ®Google Scholar
• Gu YZ, Nisbet DL, Reidy KL, Palma-Dias R. Hypoplastic nasal bone: a potential marker for facial dysmorphism associated with pathogenic copy number variants on microarray. Prenat Diagn. 2019;39(2):116–123. doi:10.1002/pd.5410
   PubMed Web of Science ®Google Scholar
• Dukhovny S, Wilkins-Haug L, Shipp TD, Benson CB, Kaimal AJ, Reiss R. Absent fetal nasal bone: what does it mean for the euploid fetus? J Ultrasound Med. 2013;32(12):2131–2134. doi:10.7863/ultra.32.12.2131
   PubMed Web of Science ®Google Scholar
• Sherer DM, Eugene P, Dalloul M, et al. Second-trimester diagnosis of cri du chat (5p-) syndrome following sonographic depiction of an absent fetal nasal bone. J Ultrasound Med. 2006;25(3):387–388. doi:10.7863/jum.2006.25.3.387
   PubMed Web of Science ®Google Scholar
• Xing Y, Holder JL Jr, Liu Y, et al. Prenatal diagnosis of Wolf-Hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counseling. Arch Gynecol Obstet. 2018;298(2):289–295. doi:10.1007/s00404-018-4798-1
   PubMed Web of Science ®Google Scholar
• On Genetics, Gynecologists Committee. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. ObstetGynecol. 2013;122(6):1374–1377.
   Google Scholar
• American College of Obstetricians and Gynecologists and others. ACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol. 2009;114(5):1161–1163. doi:10.1097/AOG.0b013e3181c33cad
   PubMedGoogle Scholar
• Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–764. doi:10.1016/j.ajhg.2010.04.006
   PubMed Web of Science ®Google Scholar
• Clark MM, Stark Z, Farnaes L, et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ GenomMed. 2018;3:16.
   PubMed Web of Science ®Google Scholar
• Yang X, Huang LY, Pan M, et al. Exome sequencing improves genetic diagnosis of fetal increased nuchal translucency. PrenatDiag. 2020;40(11):1426–1431.
   Google Scholar
• Stankiewicz P, Kulkarni S, Dharmadhikari AV, et al. Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat. 2012;33(1):165–179. doi:10.1002/humu.21614
   PubMed Web of Science ®Google Scholar
• Petrovski S, Aggarwal V, Giordano JL, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019;393(10173):758–767. doi:10.1016/S0140-6736(18)32042-7
   PubMed Web of Science ®Google Scholar
• Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. FertilSteril. 2018;109(2):201–212.
   PubMed Web of Science ®Google Scholar
• Sonek JD, McKenna D, Webb D, Croom C, Nicolaides K. Nasal bone length throughout gestation: normal ranges based on 3537 fetal ultrasound measurements. Ultrasound Obstet Gynecol. 2003;21(2):152–155. doi:10.1002/uog.41
   PubMed Web of Science ®Google Scholar
• Hung JH, Fu CY, Chen CY, Chao KC, Hung J. Fetal nasal bone length and Down syndrome during the second trimester in a Chinese population. J Obstet Gynaecol Res. 2008;34(4):518–523.
   PubMed Web of Science ®Google Scholar
• Ghai SJ, Shago M, Shroff M, Yoon G. Cockayne syndrome caused by paternally inherited 5 Mb deletion of 10q11.2 and a frameshift mutation of ERCC6. Eur J Med Genet. 2011;54(3):272–276. doi:10.1016/j.ejmg.2011.02.008
   PubMed Web of Science ®Google Scholar
• Brunetti-Pierri N, Berg JS, Scaglia F, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008;40(12):1466–1471. doi:10.1038/ng.279
   PubMed Web of Science ®Google Scholar
• Gourari I, Schubert R, Prasad A. 1q21.1 Duplication syndrome and epilepsy: case report and review. Neurol Genet. 2018;4(1):e219. doi:10.1212/NXG.0000000000000219
   PubMed Web of Science ®Google Scholar
• Guy C, Wang X, Lu X, Lu J, Li S. Clinical report: variable phenotypic expression in a large sibling cohort with a deletion of 4p16.1. Clin Case Rep. 2016;4(10):913–918. doi:10.1002/ccr3.638
   PubMedGoogle Scholar
• Battaglia A, Carey JC, South ST. Wolf-Hirschhorn syndrome: a review and update. Am J MedGenet SeminMedGenet. 2015;169(3):216–223.
   Google Scholar
• Furrow A, Theisen A, Velsher L, et al. Duplication of the STS region in males is a benign copy-number variant. Am J MedGenet SeminMedGenet. 2011;155a(8):1972–1975.
   Google Scholar
• Li F, Shen Y, Köhler U, et al. Interstitial microduplication of Xp22.31: causative of intellectual disability or benign copy number variant? Eur JMedGnet. 2010;53(2):93–99.
   Google Scholar
• Guo YW, Chiu CY, Liu CL, Jap TS, Lin LY. Novel mutation of RUNX2 gene in a patient with cleidocranial dysplasia. Int JClin ExpPathol. 2015;8(1):1057–1062.
   Web of Science ®Google Scholar
• Muzio LL, Tetè S, Mastrangelo F, et al. A novel mutation of gene CBFA1/RUNX2 in cleidocranial dysplasia. Ann ClinLabSci. 2007;37(2):115–120.
   PubMed Web of Science ®Google Scholar
• Weiss K, Terhal PA, Cohen L, et al. De novo mutations in CHD4, an ATP-dependent chromatin remodeler gene, cause an intellectual disability syndrome with distinctive dysmorphisms. Am J HumGenet. 2016;99(4):934–941. doi:10.1016/j.ajhg.2016.08.001
   PubMed Web of Science ®Google Scholar
• Ganapathi M, Nahum O, Levy B. Prenatal diagnosis using chromosomal SNP microarrays. Methods Mol Biol. 2019;1885:187–205.
   PubMedGoogle Scholar
• Callaway JL, Shaffer LG, Chitty LS, Rosenfeld JA, Crolla JA. The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. PrenatDiag. 2013;33(12):1119–1123.
   Google Scholar
• Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184. doi:10.1056/NEJMoa1203382
   PubMed Web of Science ®Google Scholar
• Gahl WA, Markello TC, Toro C, et al. The national institutes of health undiagnosed diseases program: insights into rare diseases. Gene Med. 2012;14(1):51–59. doi:10.1038/gim.0b013e318232a005
   PubMed Web of Science ®Google Scholar